Clinical trial
Phase I Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
NCT02802124 is registered in ClinicalTrials.gov with Shanghai Proton and Heavy Ion Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
- Lead sponsor
- Shanghai Proton and Heavy Ion Center
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2015
- Completion date
- October 31, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma